P-139 A phase 2 multicohort study (LEAP-005) of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors: Pancreatic cancer cohort. - Chung, H.; Villanueva, L.; Graham, D.; Saada-Bouzid, E.; Ghori, R.; Kubiak, P.; Gumuscu, B.; Lerman, N.; Gomez-Roca, C. (Annals of Oncology, 2021)